Thomas F Tedder

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Tyrosine Kinase

Inflammatory Response

Top Venues

Science translational medicine

Science signaling

This page only lists publications with an associated author ORCID identifier.

Publications

Scott Parker, Charlotte McDowall, Luis Sanchez-Perez, Cristina Osorio, Patrick C Duncker, Aaron Briley, Adam M Swartz, James E Herndon, Yen-Rei A Yu, Roger E McLendon, Thomas F Tedder, Annick Desjardins, David M Ashley, Michael Dee Gunn, David S Enterline, David A Knorr, Ira H Pastan, Smita K Nair, Darell D Bigner, Vidyalakshmi Chandramohan
Immunotoxin-αCD40 therapy activates innate and adaptive immunity and generates a durable antitumor response in glioblastoma models. Science translational medicine 15 (682) (2023)
Scott Parker, Charlotte McDowall, Luis Sanchez-Perez, Cristina Osorio, Patrick C Duncker, Aaron Briley, Adam M Swartz, James E Herndon, Yen-Rei A Yu, Roger E McLendon, Thomas F Tedder, Annick Desjardins, David M Ashley, Michael Dee Gunn, David S Enterline, David A Knorr, Ira H Pastan, Smita K Nair, Darell D Bigner, Vidyalakshmi Chandramohan
Immunotoxin-αCD40 therapy activates innate and adaptive immunity and generates a durable antitumor response in glioblastoma models. Science translational medicine 15 (682) (2023)
Scott Parker, Charlotte McDowall, Luis Sanchez-Perez, Cristina Osorio, Patrick C Duncker, Aaron Briley, Adam M Swartz, James E Herndon, Yen-Rei A Yu, Roger E McLendon, Thomas F Tedder, Annick Desjardins, David M Ashley, Michael Dee Gunn, David S Enterline, David A Knorr, Ira H Pastan, Smita K Nair, Darell D Bigner, Vidyalakshmi Chandramohan
Immunotoxin-αCD40 therapy activates innate and adaptive immunity and generates a durable antitumor response in glioblastoma models. Science translational medicine 15 (682) (2023)
Chizuru Akatsu, Amin Alborzian Deh Sheikh, Naoko Matsubara, Hiromu Takematsu, Astrid Schweizer, Hajjaj H M Abdu-Allah, Thomas F Tedder, Lars Nitschke, Hideharu Ishida, Takeshi Tsubata
The inhibitory coreceptor CD22 restores B cell signaling by developmentally regulating Cd45 -/- immunodeficient B cells. Science signaling 15 (723) (2022)